Chemical Properties:
Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer's requirement. Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation. Manufacturer Supply with High Purity and Stable Quality, Commercial Production| Item | Specifications |
| Appearance | White Crystalline Powder |
| Melting Point | 300℃ min |
| Identification | IR, NMR |
| Assay | 98.0%~102.0% |
| Loss on Drying | ≤1.0% |
| Residue on Ignition | ≤1.0% |
| Bacterial Emdotoxins | ≤5IU/mg |
| Test Standard | Enterprise Standard; Chinese Pharmacopoeia (CP) |
| Usage | Pharmaceutical Intermediates |
Description:
Specifications:
Package & Storage:
| Chemical Name | Isonipecotic Acid |
| Synonyms | 4-Piperidinecarboxylic Acid; H-DL-Inp-OH |
| CAS Number | 498-94-2 |
| CAT Number | RF-PI285 |
| Stock Status | In Stock, Production Scale Up to Tons |
| Molecular Formula | C6H11NO2 |
| Molecular Weight | 129.16 |
| Solubility | Solubility in Water: Very Faint Turbidity |
| Shipping Condition | Shipped Under Ambient Temperature |
| Brand | Ruifu Chemical |
Advantages:
FAQ:
Application:
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Isonipecotic Acid, 4-Piperidinecarboxylic Acid (CAS: 498-94-2) with high quality, widely used in organic synthesis, synthesis of pharmaceutical intermediates and Active Pharmaceutical Ingredient (API) synthesis. Isonipecotic Acid, 4-Piperidinecarboxylic Acid (CAS: 498-94-2) is an important reactant for the synthesis of alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors. It is also used in the synthesis of antibiotic nitroxoline derivatives for cathepsin B inhibition. Application Reactant for synthesis of: Antibiotic nitroxoline derivatives for cathepsin B inhibition Sphingosine-1-phosphate receptor agonists RhoA inhibitors for cardiovascular disease therapy Alkyl piperidine and piperazine hydroxamic acids as HDAC inhibitors CHK1 inhibitors IKK2 inhibitors for investigations into rheumatoid arthritis treatment
